EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Pharmacodynamic Evaluation of Highly Selective PARP1 Inhibitors with Brain Penetrance

Tao Guo, Yongting Yuan, Yurong Zou, Zhongning Guo, Tao Yang iD, Minghai Tang, Ziyan Ma, Zhiyuan Fu, Weichen Bo, Peng Wang, Peng Bai, Taijin Wang und 3 weitere

Journal of Medicinal Chemistry · 23.01.2025 · 68 (2) · 1731-1754

DOI: 10.1021/acs.jmedchem.4c02463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.01.2025. Verfasst von Tao Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Drug Design, Poly (ADP-Ribose) Polymerase-1, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, National Key Research and Development Program of China, Chengdu Zenitar Biomedical Technology Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsDrug DesignPoly (ADP-Ribose) Polymerase-1Antineoplastic AgentsHumansAnimalsMiceCell Line, TumorFemaleBlood-Brain BarrierStructure-Activity RelationshipCell ProliferationXenograft Model Antitumor AssaysBrainMice, NudeAdministration, Oral

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPoly (ADP-Ribose) Polymerase-1PARP1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Chengdu Zenitar Biomedical Technology Co., Ltd., Chengdu 610041, China.

ORCID-Profile: Tao Yang, Lijuan Chen

Förderung

  • West China Hospital, Sichuan University
  • National Key Research and Development Program of China
  • Chengdu Zenitar Biomedical Technology Co., Ltd.

Zitieren

APA

Guo, T., Yuan, Y., Zou, Y., Guo, Z., Yang, T., Tang, M., Ma, Z., Fu, Z., Bo, W., Wang, P., Bai, P., Wang, T., Jia, T., Yang, J., & Chen, L. (2025). Design, Synthesis, and Pharmacodynamic Evaluation of Highly Selective PARP1 Inhibitors with Brain Penetrance. Journal of Medicinal Chemistry, 68(2), 1731-1754. https://doi.org/10.1021/acs.jmedchem.4c02463

Vancouver

Guo T, Yuan Y, Zou Y, Guo Z, Yang T, Tang M, et al. Design, Synthesis, and Pharmacodynamic Evaluation of Highly Selective PARP1 Inhibitors with Brain Penetrance. Journal of Medicinal Chemistry. 2025;68(2):1731-1754. doi:10.1021/acs.jmedchem.4c02463

BibTeX
@article{Guo2025,
  author = {Guo, Tao and Yuan, Yongting and Zou, Yurong and Guo, Zhongning and Yang, Tao and Tang, Minghai and Ma, Ziyan and Fu, Zhiyuan and Bo, Weichen and Wang, Peng and Bai, Peng and Wang, Taijin and Jia, Tao and Yang, Jianhong and Chen, Lijuan},
  title = {Design, Synthesis, and Pharmacodynamic Evaluation of Highly Selective PARP1 Inhibitors with Brain Penetrance},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {2},
  pages = {1731--1754},
  doi = {10.1021/acs.jmedchem.4c02463}
}
Kostenlos starten →